Brief introduction of SM-1 project
2020-06-09
The advantage of project：
Ø Taking Procaspase-3 as the target, it has unique advantages and characteristics in the mechanism of action.
Ø High selectivity, low toxicity and side effect, no drug resistance.
Ø Multiple indications are effective for tumor cells with high procaspase-3 content.
Ø The blood-brain barrier could be used as a potential orphan drug for the treatment of brain tumors.
Ø The target is clear, clinical can be combined with the patient's situation to carry out individual treatment.
Ø Oral medicine, easy to take.
